关注
Jyotiprakash Bhanja
Jyotiprakash Bhanja
Medical Writer, CRO Pharmatrendz Pvt. Ltd.
在 pharmatrendz.com 的电子邮件经过验证
标题
引用次数
引用次数
年份
A Review of Immune Blockade Safety and Antitumor Activity of Dostarlimab Therapy in Endometrial Cancer
P Saha, A Kumar, J Bhanja, R Shaik, AL Kawale, R Kumar
International Journal for Research in Applied Sciences and Biotechnology 9 …, 2022
522022
A Review on Different Methods of Preparation and Therapeutic Applications of Curcumin Nanoparticles
Jyotiprakash Bhanja, Anupam Pal, Saroj Kumar Raul, Sabyasachi Krushna Gopal ...
International Journal of Pharmaceutical Research and Applications 7 (5), 393-403, 2022
2022
RISK FACTORS FOR ATHEROSCLEROSIS
J Bhanja, S Shukla, M Jena, R Palit, M Lopamudra
2022
系统目前无法执行此操作，请稍后再试。
文章 1–3